CXCR7 in tumorigenesis and progression - PubMed (original) (raw)
Review
CXCR7 in tumorigenesis and progression
Kai-Lin Hou et al. Chin J Cancer. 2010 Apr.
Free article
Abstract
Chemokines, a family of small cytokines, were initially characterized as proinflammatory chemoattractant cytokines that regulated cell trafficking and adhesion. Today, attention focuses on chemokines because evidence shows that they play a critical role in tumor initiation, promotion, and progression. CXCR7, a seven-transmembrane G-protein-coupled CXC chemokine receptor, has recently been identified as binding with high affinity to chemokines CXCL11 (I-TAC) and CXCL12 (SDF-1). In this review, we highlight the current knowledge about the role of CXCR7 in the biologic processes of cancer, including cancer growth, survival, adhesion, invasion, metastasis, angiogenesis, and progression. The use of peptides, small molecules, antibodies, or small interfering RNA to target CXCR7 shows promise as new potential avenues for the treatment of cancer.
Similar articles
- SDF-1/CXCR7 axis regulates the proliferation, invasion, adhesion, and angiogenesis of gastric cancer cells.
Ma DM, Luo DX, Zhang J. Ma DM, et al. World J Surg Oncol. 2016 Oct 6;14(1):256. doi: 10.1186/s12957-016-1009-z. World J Surg Oncol. 2016. PMID: 27716367 Free PMC article. - Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.
Singh AK, Arya RK, Trivedi AK, Sanyal S, Baral R, Dormond O, Briscoe DM, Datta D. Singh AK, et al. Cytokine Growth Factor Rev. 2013 Feb;24(1):41-9. doi: 10.1016/j.cytogfr.2012.08.007. Epub 2012 Sep 16. Cytokine Growth Factor Rev. 2013. PMID: 22989616 Free PMC article. Review. - [Recent advances and applications of CXCR7].
Shen Q, Wang F. Shen Q, et al. Zhonghua Bing Li Xue Za Zhi. 2009 May;38(5):358-60. Zhonghua Bing Li Xue Za Zhi. 2009. PMID: 19575889 Review. Chinese. No abstract available. - A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.
Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, Kuo CJ, Wei K, McMaster BE, Wright K, Howard MC, Schall TJ. Burns JM, et al. J Exp Med. 2006 Sep 4;203(9):2201-13. doi: 10.1084/jem.20052144. Epub 2006 Aug 28. J Exp Med. 2006. PMID: 16940167 Free PMC article. - Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
Nazari A, Khorramdelazad H, Hassanshahi G. Nazari A, et al. Int J Clin Oncol. 2017 Dec;22(6):991-1000. doi: 10.1007/s10147-017-1187-x. Epub 2017 Oct 11. Int J Clin Oncol. 2017. PMID: 29022185 Review.
Cited by
- CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not.
Neve Polimeno M, Ierano C, D'Alterio C, Simona Losito N, Napolitano M, Portella L, Scognamiglio G, Tatangelo F, Maria Trotta A, Curley S, Costantini S, Liuzzi R, Izzo F, Scala S. Neve Polimeno M, et al. Cell Mol Immunol. 2015 Jul;12(4):474-82. doi: 10.1038/cmi.2014.102. Epub 2014 Nov 3. Cell Mol Immunol. 2015. PMID: 25363530 Free PMC article. - Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.
Zhou W, Guo S, Liu M, Burow ME, Wang G. Zhou W, et al. Curr Med Chem. 2019;26(17):3026-3041. doi: 10.2174/0929867324666170830111531. Curr Med Chem. 2019. PMID: 28875842 Free PMC article. Review. - Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis.
Ghanem I, Riveiro ME, Paradis V, Faivre S, de Parga PM, Raymond E. Ghanem I, et al. Am J Transl Res. 2014 Jul 18;6(4):340-52. eCollection 2014. Am J Transl Res. 2014. PMID: 25075251 Free PMC article. Review. - Bioinformatics identification and validation of biomarkers and infiltrating immune cells in endometriosis.
Jiang H, Zhang X, Wu Y, Zhang B, Wei J, Li J, Huang Y, Chen L, He X. Jiang H, et al. Front Immunol. 2022 Nov 29;13:944683. doi: 10.3389/fimmu.2022.944683. eCollection 2022. Front Immunol. 2022. PMID: 36524127 Free PMC article. - Rationale for the design of an oncology trial using a generic targeted therapy multi‑drug regimen for NSCLC patients without treatment options (Review).
Langhammer S. Langhammer S. Oncol Rep. 2013 Oct;30(4):1535-41. doi: 10.3892/or.2013.2631. Epub 2013 Jul 22. Oncol Rep. 2013. PMID: 23877481 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources